Inspection

  1. The Sensitivity Trap: Building Confidence In CCIT Performance 3/2/2026

    Effective CCIT goes beyond micron claims, focusing instead on repeatability, confidence, and real‑world relevance. Learn how to define a defensible LOD and understand what auditors truly prioritize.

  2. Early-Stage Considerations For The Selection Of Pre-Fillable Syringes When Developing A Vaccine 5/14/2021

    Get an overview of the strategy to speed up the migration from a vial to a pre-fillable syringe. Explore the main considerations in meeting and overcoming PFS-drug challenges when developing a vaccine.

  3. Advanced CCIT Strategies For Combination Products 7/14/2026

    Gain insight into how deterministic CCIT methods support sterility assurance, product stability, and patient safety for prefilled syringes, auto-injectors, and other combination products.

  4. Design, Statistical Tools For Package Integrity Testing Systems 3/26/2020

    This short podcast focuses on experimental design and statistical tools we use with non-destructive package integrity test systems that produce reliable and robust quantitative test data.

  5. A Practical Road Map For Compliance To EU GMP Annex 1

    Learn how to interpret the Annex 1 container closure requirements, develop deterministic analytical methods for CCIT, and design packaging studies that generate robust data demonstrating good CCI.

  6. Important Considerations When Evaluating Manual vs. Automated Vision Inspection Systems 3/31/2020

    This webinar takes a look at the pros and cons of manual visual inspection. Join us in taking a deeper dive into this probabilistic test method.

  7. Container Closure Integrity Of Product Requiring Deep Cold Storage 8/26/2022

    Gain insight into the risk to container closure integrity (CCI) during deep cold storage and identify appropriate analytical tools, to generate robust data to characterize and mitigate the risk to CCI.

  8. USP <922> Water Activity Has Opened A Door For OSD Manufacturers 6/20/2022

    Learn more about USP <922> Water Activity and why using Karl-Fischer titration to measure total water content is no longer adequate to fully understand the stability of oral solid dosage products.

  9. The Container Closure Integrity Requirements In The Revised EU Annex 1

    Learn about the advantages and disadvantages of CCI testing methods, how the revised EU Annex 1 may impact your strategy for ensuring CCI of sterile pharmaceutical products, and more.

  10. Protecting Oxygen Sensitive Formulations Throughout Product Life Cycle 5/19/2021

    This webinar reviews how oxygen levels in finished parenteral drug containers can be determined and controlled throughout the product life cycle by using laser-based headspace analysis.